A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Using Subjective and Objective Measures to Evaluate the Clinical Efficacy of Mometasone Furoate Nasal Spray (MFNS) [mometasone] Following Initial and Maintenance Dosing in Subjects With Allergen-Induced Seasonal Allergic Rhinitis (SAR) in an Environmental Exposure Chamber (EEC).
Phase of Trial: Phase IV
Latest Information Update: 30 May 2014
At a glance
- Drugs Mometasone (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 06 Apr 2010 Planned number of patients changed from 300 to 310 as reported by ClinicalTrials.gov.
- 13 Jul 2007 New trial record.